Professor Jason Chuah FRSA SFHEA holds the Chair of Commercial and Maritime Law at the City Law School, UK. He has recently been appointed as a Dean of Faculty of Law at the University of Malaya, Malaysia. He was the holder of the Cambridge Commonwealth Trust Award, Barclays Bank Scholarship and the Cambridge Commonwealth Fellowship at Cambridge University. His PhD looked at the influence of the need for commercial certainty on the judicial development of commercial and maritime law. He also has a Professional Certificate in Export with Distinction from the UK Institute of Export. He holds a First Class Hons degree in Law from the University of Malaya. He has written thirteen books and well over 200 articles. He is editor of several international journals, including the Journal of International Maritime Law, International Company and Commercial Law Review, International Trade Law and Regulation, Shipping & Trade Law, International Transport Law Review, and Finance & Credit Law. He has served on research councils in the UK, South Africa, Poland, Canada and Colombia. His work has been cited by institutions in the UK, US, EU and Asia. He is also Executive Director of the London Universities Maritime Law and Policy Group. He has been involved in various consultations with the Ministry of Justice, the OECD, the ICC, the Association of British Insurers, the UNCITRAL, etc.

Dr Arindam was born and raised in Kolkata (India) and he did his B.Sc. with Biotechnology (Jiwaji University, India) and M.Sc. in Marine Biology at the Pondicherry University (India). For his Doctoral degree in Marine micropalaeontology at the Birbal Sahni Institute of Palaeosciences (BSIP), India / University of Burdwan he worked on the Neogene microfossils and palaeoclimate of Andaman and Nicobar Islands. He had the opportunity to travel internationally (UK, Scotland, France, Germany, Italy, Greece, Thailand, Poland, Taiwan, France, Turkey, Indonesia) and nationally to attend conferences and collaborated research work. His postdoctoral experience in India as a National Post-doctoral fellow (NPDF, 2017-2019) and Birbal Sahni Research Associate (BSRA, 2019-2022) at BSIP (India) was to understand the Neogene climate of northern Indian Ocean. During April, 2022 he joined the Stable Isotope laboratory at Institute of Earth Sciences (IES), Academia Sinica (Taiwan) as a Postdoctoral Researcher and worked on triple oxygen isotopes and silicon isotopes from diatoms. He is currently working as a Senior Lecturer at the Department of Geology, Faculty of Science, Universiti Malaya, Kuala Lumpur, Malaysia since March, 2023. Other than the teaching responsibilities his research is focused on the palaeoclimatic variability during the geological history. He use microfossils (mainly siliceous microfossils and calacreous nannofossils) and their chemistry to determine patterns of global climatic conditions and ecology. He is also currently working on samples from International Ocean Drilling Program Expedition 342 (North Atlantic), Integrated Ocean Drilling Program Expedition 378 (South Pacific) and Integrated Ocean Drilling Program Expedition 391 (South Indian). He is also the Supervisor of the Geology Museum, Universiti Malaya. Dr Arindam is the Associate Fellow of Academy Sains Malaysia, Membership Secretary of The Micropalaeontological Society (UK) and also nominated member of Risk-KAN 'Past4future' Working group. 

Dr Lai Lee Lee, BNurSc (Hons) (Major Teaching), MMedSci (Anesthesiology) and PhD MedSci (Medicine) Dr Lai is a senior lecturer at Universiti Malaya and Clinical Researcher in Oncoplastic Breast Unit at Universiti Malaya Medical Center (UMMC). She is actively involved in different areas of clinical research at Universiti Malaya. Her area of interest is mainly in Clinical Breast Surgical Oncology such as new techniques such as minimally invasive breast surgeries (endoscopic), ERAS in Breast Reconstruction, and developing Decision Aid in Breast Reconstruction. Apart from this, she is very active in clinical trials such as breast cancer oncological treatments such as few clinical trials such as the risk for breast cancer, Intraoperative Radiotherapy (TARGIT B Trial), improving outcomes for breast-conserving surgery and oncology treatment for breast cancer, Biomarkers research for breast cancers, Epidemiology research, Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) and Non-alcoholic steatohepatitis (NASH) research.